Selvita SA (SLV):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Selvita SA (SLV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8158
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポーランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Selvita SA (Selvita) is a drug discovery company that focuses on the research and development of cancer therapies. The company develops novel small molecule drugs, and markets them with partners from the pharmaceutical industry. Its products find application in the therapeutic areas of oncology, inflammation, leukemia, lymphoma, solid tumors and hematological malignancies. Selvita also offers services such as contract chemistry services, biology services, drug discovery services, computational chemistry, medicinal chemistry, analytical services, preclinical research, and quality assurance services. The company caters to pharmaceutical and biotechnology companies. It has presence in Poland, the US and the UK. Selvita is headquartered in Krakow, Poland.

Selvita SA (SLV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Selvita SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Selvita SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Selvita SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Selvita SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Selvita SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Selvita SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Selvita Enters into Agreement with Leukemia & Lymphoma Society 10
Selvita Enters into Agreement with Nodthera 11
Selvita Enters into Agreement with University of California, San Francisco 12
Selvita Enters into Agreement with Merck 13
Selvita Enters into Development and Commercialization Agreement with Merck 14
Felicitex Therapeutics Enters into Co-Development Agreement with Selvita 15
Merck Serono Enters Into Co-Development Agreement With Selvita For Cancer Drugs 16
H3 Biomedicine Extends Agreement with Selvita 17
Licensing Agreements 18
Berlin-Chemie Enters into Licensing Agreement with Selvita 18
Merck Enters into Licensing Agreement with Selvita 19
Equity Offering 20
Selvita Raises USD40.3 Million in Public Offering of Shares 20
Selvita Raises USD0.1 Million in Private Placement of Shares 21
Selvita Raises USD8 Million in IPO 22
Selvita SA – Key Competitors 24
Selvita SA – Key Employees 25
Selvita SA – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Sep 11, 2018: Selvita announces H1 2018 financial results 27
May 25, 2018: Selvita reports strong business growth in Q1 2018 28
Apr 04, 2018: Selvita shows a very strong, 60% business growth in 2017 29
Sep 15, 2017: Selvita Demonstrates Strong Revenue Growth in H1 2017 30
May 31, 2017: Selvita doubles the revenue in Q1 2017 vs. Q1 2016 31
Apr 20, 2017: Selvita Shows 19% Business Growth in 2016 32
Corporate Communications 33
Feb 06, 2018: Selvita Appoints Steffen Heeger, M.D., PhD as Chief Medical Officer 33
Product News 34
Feb 13, 2017: Selvita researchers publish MNK inhibitors review in Current Medicinal Chemistry 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Selvita SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Selvita SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Selvita SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Selvita SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Selvita SA, Deals By Therapy Area, 2012 to YTD 2018 8
Selvita SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Selvita Enters into Agreement with Leukemia & Lymphoma Society 10
Selvita Enters into Agreement with Nodthera 11
Selvita Enters into Agreement with University of California, San Francisco 12
Selvita Enters into Agreement with Merck 13
Selvita Enters into Development and Commercialization Agreement with Merck 14
Felicitex Therapeutics Enters into Co-Development Agreement with Selvita 15
Merck Serono Enters Into Co-Development Agreement With Selvita For Cancer Drugs 16
H3 Biomedicine Extends Agreement with Selvita 17
Berlin-Chemie Enters into Licensing Agreement with Selvita 18
Merck Enters into Licensing Agreement with Selvita 19
Selvita Raises USD40.3 Million in Public Offering of Shares 20
Selvita Raises USD0.1 Million in Private Placement of Shares 21
Selvita Raises USD8 Million in IPO 22
Selvita SA, Key Competitors 24
Selvita SA, Key Employees 25
Selvita SA, Other Locations 26
Selvita SA, Subsidiaries 26

List of Figures
Selvita SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Selvita SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Selvita SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Selvita SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Selvita SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Selvita SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Selvita SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Selvita SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Selvita SA (SLV):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ignyta Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc, a subsidiary of F. Hoffmann-La Roche Ltd, is a cancer care service provider. The company discovers, develops and commercializes new drugs targeting activated genes in cancer cells. It develops products using integrated therapeutic technology (Rx/Dx). …
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • ARRIS International PLC:企業の戦略的SWOT分析
    ARRIS International PLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Nihon Kohden Corp (6849):医療機器:M&Aディール及び事業提携情報
    Summary Nihon Kohden Corp (Nihon Kohden) is a provider of medical electronic equipment to support treatment in clinical areas of emergency response; testing, diagnosis, treatment, and rehabilitation. Its major products include patient monitors, electroencephalographs, evoked potential and electromyo …
  • Airservices Australia:企業の戦略的SWOT分析
    Airservices Australia - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Abreos Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information …
  • Rio Grande Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Rio Grande Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • SAP SE (SAP):企業の財務・戦略的SWOT分析
    SAP SE (SAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Vyome Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Vyome Biosciences Pvt Ltd (Vyome) is a research center that develops drugs for antibiotics-resistant acne and other opportunist pathogens. The center’s platforms modify active agents based on genomic information of the disease causing micro organism. Its pro-drug platform develops therapeuti …
  • Vergnet SA (ALVER)-エネルギー分野:企業M&A・提携分析
    Summary Vergnet SA (Vergnet) is a renewable energy company. It designs, develops, and manufactures renewable solutions. The company offers wind, solar and hybrid energy solutions besides solar applications. Through its technology Hybrid Wizard, Vergnet offers real-time hybrid controller solutions fo …
  • HDI-Global SE:企業の戦略・SWOT・財務情報
    HDI-Global SE - Strategy, SWOT and Corporate Finance Report Summary HDI-Global SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • SunEdison Inc (SUNEQ)-エネルギー分野:企業M&A・提携分析
    Summary SunEdison, Inc. (SunEdison) is a solar energy company that develops and sells photovoltaic energy solutions, and owns and operates clean power generation assets. The company also develops, manufactures and sells silicon wafer for the semiconductor industry. It also offers solar energy servic …
  • Rollprint Packaging Products Inc.:企業の戦略・SWOT・財務情報
    Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report Summary Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Transgenomic Inc (TBIO)-医療機器分野:企業M&A・提携分析
    Summary Transgenomic Inc (Transgenomic) is a developer and provider of diagnostic tools and services. The company’s products include ICEme Kits, and genetic assays and platforms. It offers genetic assays and platforms such as PCR reagents, chromatography, genetic analysis kits, hanabi cytogenetic sy …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd, is an upstream oil and gas exploration and production company. The company explores, produces, and develops, oil and gas properties in Trinidad and Tobago. It holds interests in projects such as South Palo Seco, New …
  • Sino Oil and Gas Holdings Ltd (702):石油・ガス:M&Aディール及び事業提携情報
    Summary Sino Oil and Gas Holdings Ltd (Sino Oil and Gas), formerly Genesis Energy Holdings Ltd, is an oil and gas company that offers production and development of oil properties. The company offers services such as oil and gas exploration, production, distribution, development and supplying service …
  • Chennai Petroleum Corporation Ltd (CHENNPETRO):企業の財務・戦略的SWOT分析
    Chennai Petroleum Corporation Ltd (CHENNPETRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Fortress Biotech Inc (FBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Fortress Biotech Inc (Fortress), formerly Coronado Biosciences Inc is a biopharmaceutical company that develops and commercializes pharmaceutical and biotechnology products. The company offers products in the areas of dermatology, cancer, pain management and autoimmune diseases, among others …
  • China Mobile Limited:企業の戦略・SWOT・財務情報
    China Mobile Limited - Strategy, SWOT and Corporate Finance Report Summary China Mobile Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Menarini Group:企業のM&A・事業提携・投資動向
    The Menarini Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Menarini Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆